Danilo Roman‐Campos

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

Peripheral Blood Signature of Vasodilator-Responsive Pulmonary Arterial Hypertension

Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China

A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension

Haemodynamic definitions and updated clinical classification of pulmonary hypertension

Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis

Definitions and Diagnosis of Pulmonary Hypertension

A global view of pulmonary hypertension

Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era

Mechanisms of NAFLD development and therapeutic strategies

Molecular response of Musca domestica L. to Mintostachys verticillata essential oil, (4R)(+)-pulegone and menthone

Updated Clinical Classification of Pulmonary Hypertension

Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study

Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness

Chemotherapy-Induced Pulmonary Hypertension

The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report—2017; Focus Theme: Allograft ischemic time

Relevant Issues in the Pathology and Pathobiology of Pulmonary Hypertension

Genetics and Genomics of Pulmonary Arterial Hypertension

Naringenin Inhibits Superoxide Anion-Induced Inflammatory Pain: Role of Oxidative Stress, Cytokines, Nrf-2 and the NO−cGMP−PKG−KATPChannel Signaling Pathway

Complex genetics of pulmonary diseases: lessons from genome-wide association studies and next-generation sequencing

Essential oils: From extraction to encapsulation

Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension

The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes

Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension

The Therapeutic Potential of Naringenin: A Review of Clinical Trials

Flavonoids as Potential Anti-Inflammatory Molecules: A Review

Calcitonin Gene-Related Peptide Regulates Cardiomyocyte Survival through Regulation of Oxidative Stress by PI3K/Akt and MAPK Signaling Pathways.

Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)–Induced Pulmonary Hypertension

The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)

R(+)-pulegone impairs Ca2+ homeostasis and causes negative inotropism in mammalian myocardium

A Novel Channelopathy in Pulmonary Arterial Hypertension

Functional Cross-Talk Between Aldosterone and Angiotensin-(1-7) in Ventricular Myocytes

Morphine peripheral analgesia depends on activation of the PI3Kγ/AKT/nNOS/NO/K _ATP signaling pathway